Showing results 1 to 20 of 109
next >
| Issue Date | Title | Author(s) |
| 20-May-2021 | Adjuvant anti-PD-1 ab (Toripalimab) versus high-dose IFN-a2b in resected mucosal melanoma: A phase randomized trial. | Cui, Chuanliang; Lian, Bin; Si, Lu; Chi, Zhihong; Sheng, Xinan; Kong, Yan; Wang, Xuan; Tian, Hui; Mao, Lili; Bai, Xue; Tang, Bixia; Yan, Xieqiao; Li, Siming; Zhou, Li; Guo, Jun |
| 20-May-2021 | Adjuvant radiotherapy plus systemic chemotherapy in resected head and neck mucosal melanoma. | Duan, Rong; Tang, Bixia; Chi, Zhihong; Cui, Chuanliang; Lian, Bin; Li, Siming; Mao, Lili; Yan, Xieqiao; Wang, Xuan; Bai, Xue; Zhou, Li; Wei, Xiaoting; Guo, Jun; Sheng, Xinan |
| 2016 | Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors | Kong, Yan; Si, Lu; Li, Yiqian; Wu, Xiaowen; Xu, Xiaowei; Dai, Jie; Tang, Huan; Ma, Meng; Chi, Zhihong; Sheng, Xinan; Cui, Chuanliang; Guo, Jun |
| 2015 | Analysis of mTOR Mutations in Chinese Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors | Kong, Yan; Si, Lu; Li, Yi Qian; Wu, Xiao Wen; Xu, Xiao Wei; Dai, Jie; Tang, Huan; Ma, Meng; Chi, Zhihong; Sheng, Xi Nan; Cui, Chuanliang; Guo, Jun |
| 2018 | Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor | Yan, Junya; Wu, Xiaowen; Yu, Jiayi; Yu, Huan; Xu, Tianxiao; Brown, Kevin M.; Bai, Xue; Dai, Jie; Ma, Meng; Tang, Huan; Si, Lu; Chi, Zhihong; Sheng, Xinan; Cui, Chuanliang; Kong, Yan; Guo, Jun |
| 2018 | Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients | Yu, Jiayi; Wu, Xiaowen; Yan, Junya; Yu, Huan; Xu, Longwen; Chi, Zhihong; Sheng, Xinan; Si, Lu; Cui, Chuanliang; Dai, Jie; Ma, Meng; Xu, Tianxiao; Kong, Yan; Guo, Jun |
| 2017 | Anti-VEGFR, PDGFR, and CSF1R tyrosine kinase inhibitor CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma: a phase 1 clinical trial | Yan, Xieqiao; Sheng, Xinan; Tang, Bixia; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Mao, Li Li; Lian, Bin; Li, Siming; Zhou, Li; Wang, Xuan; Bai, Xue; Kong, Yan; Dai, Jie; Guo, Jun |
| Jun-2023 | Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancer | Lei, Huizi; Ling, Yun; Yuan, Pei; Yan, Xieqiao; Wang, Lin; Shi, Yanxia; Yao, Xin; Luo, Hong; Shi, Benkang; Liu, Jiyan; He, Zhisong; Yu, Guohua; Han, Weiqing; Hu, Changlu; Chi, Zhihong; Cui, Chuanliang; Si, Lu; Fang, Jianmin; Guo, Jun; Sheng, Xinan; Zhou, Aiping; Ying, Jianming |
| 5-Jul-2021 | Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical Trials | Zhou, Li; Wang, Xuan; Chi, Zhihong; Sheng, Xinan; Kong, Yan; Mao, Lili; Lian, Bin; Tang, Bixia; Yan, Xieqiao; Bai, Xue; Li, Siming; Guo, Jun; Cui, Chuanliang; Si, Lu |
| Jan-2021 | Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy | Wang, Xuan; Xu, Weiran; Chi, Zhihong; Si, Lu; Sheng, Xinan; Kong, Yan; Zhou, Li; Mao, Lili; Lian, Bin; Tang, Bixia; Yan, Xieqiao; Bai, Xue; Cui, Chuanliang; Guo, Jun |
| 20-Feb-2022 | Clinical characteristics of patients with collecting duct carcinoma. | Zhou, Li; Li, Siming; Yan, Xieqiao; Xu, Huayan; Li, Juan; Wu, Xiaowen; Chi, Zhihong; Si, Lu; Cui, Chuanliang; Kong, Yan; Guo, Jun; Sheng, Xinan |
| 2011 | Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases | Chi, Zhihong; Li, Siming; Sheng, Xinan; Si, Lu; Cui, Chuanliang; Han, Mei; Guo, Jun |
| 2015 | Clinical presentation, systemic therapy and prognosis of mucosal melanoma, a study of 463 consecutive cases. | Zhou, Li; Cui, Chuanliang; Lian, Bin; Si, Lu; Chi, Zhihong; Sheng, Xi Nan; Mao, Li Li; Wang, Xuan; Tang, Bixia; Yan, Xieqiao; Guo, Jun |
| 2015 | Clinical presentation, systemic therapy and prognosis of mucosal melanoma, a study of 463 consecutive cases. | Zhou, Li; Cui, Chuanliang; Lian, Bin; Si, Lu; Chi, Zhihong; Sheng, Xi Nan; Mao, Li Li; Wang, Xuan; Tang, Bixia; Yan, Xieqiao; Guo, Jun |
| 2019 | A clinical prognosis model for Asian advanced melanoma patients receiving immunotherapy. | Wang, Xuan; Yan, Xiegiao; Chi, Zhihong; Si, Lu; Sheng, Xinan; Kong, Yan; Mao, Lili; Lian, Bin; Tang, Bixia; Zhou, Li; Cui, Chuanliang; Guo, Jun |
| Aug-2022 | Clinical-Kidney cancer Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma | Zhou, Li; Liu, Yiqiang; Mo, Jiazhi; Cui, Chuanliang; Chi, Zhihong; Si, Lu; Kong, Yan; Yan, Xieqiao; Li, Siming; Wu, Xiaowen; Li, Juan; Xu, Huayan; Cao, Dengfeng; Guo, Jun; Sheng, Xinan |
| Apr-2020 | The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma | Wei, Xiaoting; Wu, Di; Li, Hang; Zhang, Rui; Chen, Yu; Yao, Hong; Chi, Zhihong; Sheng, Xinan; Cui, Chuanliang; Bai, Xue; Qi, Zhonghui; Li, Ke; Lan, Shijie; Chen, Lizhu; Guo, Rui; Yao, Xinyu; Mao, Lili; Lian, Bin; Kong, Yan; Dai, Jie; Tang, Bixia; Yan, Xieqiao; Wang, Xuan; Li, Siming; Zhou, Li; Balch, Charles M.; Si, Lu; Guo, Jun |
| 2015 | COMPARISON OF CLINICAL PRESENTATION AND PROGNOSES BETWEEN ACRAL CUTANEOUS MELANOMA AND NON-ACRAL CUTANEOUS MELANOMA | Yan, Xieqiao; Chi, Zhihong; Sheng, Xinan; Si, Lu; Cui, Chuanliang; Kong, Yan; Tang, Bixia; Wang, Xuan; Mao, Lili; Lian, Bin; Guo, Jun |
| 2015 | Comparison of clinical presentation and prognosis between acral cutaneous melanoma and non-acral cutaneous melanoma. | Yan, Xieqiao; Chi, Zhihong; Sheng, Xi Nan; Si, Lu; Cui, Chuanliang; Kong, Yan; Tang, Bixia; Mao, Li Li; Wang, Xuan; Lian, Bin; Guo, Jun |
| 2015 | Comparison of clinical presentation and prognosis between acral cutaneous melanoma and non-acral cutaneous melanoma. | Yan, Xieqiao; Chi, Zhihong; Sheng, Xi Nan; Si, Lu; Cui, Chuanliang; Kong, Yan; Tang, Bixia; Mao, Li Li; Wang, Xuan; Lian, Bin; Guo, Jun |
